American Psychiatric Association
1000 Wilson Boulevard
Suite 1825
Arlington
Virginia
22209
United States
Tel: 703-907-7300
Website: http://www.psych.org/
Email: apa@psych.org
62 articles about American Psychiatric Association
-
Texas’ top law enforcement official is taking aim at two drug companies over what he alleges is the promotion of hormone blockers for children experiencing gender dysphoria.
-
Dr. Seth Resnick, AdvantageCare Physicians' Chair of Psychiatry, Named Distinguished Fellow by American Psychiatric Association
1/24/2020
Dr. Seth Resnick, Chair of the Psychiatry and Behavioral Health Department for AdvantageCare Physicians, has been named a Distinguished Fellow of the American Psychiatric Association for his significant contributions to the psychiatric field..
-
Minnesota's Psychiatric Assistance Line receives the 2019 Community Gold Award from the American Psychiatric Association
10/3/2019
The American Psychiatric Association recognized the state of Minnesota as a national leader in increasing access to psychiatric health care.
-
New Real-World Evidence Highlights Need for Interventions to Improve Outcomes for Patients Who Have Been Diagnosed with Major Depressive Disorder (MDD) and Suicide Ideation or Attempt
5/18/2019
Janssen Pharmaceutical Companies of Johnson & Johnson presented new real-world data at the American Psychiatric Association 2019 Meeting which suggest that, among adult patients with major depressive disorder, psychiatric treatment in the year prior to a diagnosis of suicide ideation or attempt is markedly low.
-
Allergan to Present VRAYLAR® (cariprazine) Data at the American Psychiatric Association (APA) 2019 Annual Meeting Highlighting Continued Commitment to Mental Health
5/15/2019
Allergan plc announced it will showcase data during the upcoming American Psychiatric Association (APA) Annual Meeting in San Francisco, May 18 – May 22, 2019.
-
Alkermes to Showcase Leadership in Schizophrenia With New Data Presentations at Upcoming Scientific Conferences
5/13/2019
Clinical Data and Health Economics and Outcomes Research to be Presented May 18-22, 2019 at APA and ISPOR Annual Meetings
-
Alkermes to Present Clinical Data at Upcoming American Psychiatric Association Annual Meeting
4/30/2018
Alkermes plc announced the presentation of six posters highlighting data from the company's schizophrenia and depression portfolios at the 2018 American Psychiatric Association (APA) Annual Meeting in New York, May 5-9, 2018.
-
Sunovion Announces Positive Results From Pivotal Study Evaluating Novel Drug Candidate Dasotraline In Adults With Binge Eating Disorder At Annual American Psychiatric Association Meeting
5/24/2017
-
Ironshore Pharma Presents Pivotal Trial Data At American Psychiatric Association Meeting
5/24/2017
-
Sunovion Announces Positive Results From Study Evaluating Latuda (Lurasidone HCL) In Children And Adolescents With Bipolar Depression At Annual American Psychiatric Association Meeting
5/22/2017
-
Teva To Present Data For Deutetrabenazine In Tardive Dyskinesia At The American Psychiatric Association 2017 Annual Meeting
5/17/2017
-
Sunovion Data Presentations At Annual American Psychiatric Association Meeting Showcase Growing Psychiatry Franchise
5/16/2017
-
Researchers Press American Psychiatric Association To Retract A Study
8/3/2016
-
Takeda And Lundbeck Inc. Present Vortioxetine Data At The American Psychiatric Association 2016 Annual Meeting
5/17/2016
-
Otsuka Pharmaceutical Development & Commercialization, Inc. To Present Scientific Data At American Psychiatric Association Annual Meeting
5/16/2016
-
Sunovion Pharmaceuticals Inc. To Present Data On Latuda (Lurasidone Hcl) At The 169th Annual Meeting Of The American Psychiatric Association
5/12/2016
-
Shire To Present New Research At 2016 American Psychiatric Association Annual Meeting
5/12/2016
-
Janssen Pharmaceutical Announces 15 Key Research Presentations At Annual Meeting Of The American Psychiatric Association
5/12/2016
-
Allergan And Gedeon Richter To Present Data On Cariprazine At The American Psychiatric Association Annual Meeting
5/12/2016
-
Neurocrine Biosciences Announces Additional Valbenazine (NBI-98854) Data To Be Presented At The American Psychiatric Association's 2016 Annual Meeting In Atlanta
5/6/2016